Drawing for COSM

USPTO serial 98033392

COSM

Reviewed by CopyMark Law Group

Status 653
Filing date
Status date
Registration date
—
Examiner
YONTEF, DAVID ERIC
Law office
TMO LAW OFFICE 118

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with COSM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lisa Adams

Lisa Adams Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo P.C.One Financial CenterBoston, MA 02111United States

Goods and services

ClassDescriptionStatusFirst use
010Medical devices for preventing female stress urinary incontinence, urinary incontinence and prolapse of pelvic organs; medical devices for treating and diagnosing urinary incontinence and prolapse of pelvic organs; medical devices, namely, pessaries for managing symptoms of female stress urinary incontinence, urinary incontinence and prolapse of pelvic organs; medical intra-vaginal devices, namely, pessaries for therapeutic purposes; medical devices for intervaginal use, namely, infusion and injection devices and syringes for administering pharmaceutical agents, namely, hormones, spermicides, proteins, and regenerative medicines; gynecological medical instruments for examining women's reproductive organs; gynecological medical devices for dimensional measurement of a women's reproductive organs, namely, 3D scanner for human bodyACTIVE—
035Retail and online retail shop services featuring user-specific medical devices for preventing female stress urinary incontinence, urinary incontinence and prolapse of pelvic organs; retail store services featuring user-specific medical devices for treating and diagnosing urinary incontinence and prolapse of pelvic organs; retail store services featuring user-specific medical devices, namely, pessaries for managing symptoms of female stress urinary incontinence, urinary incontinence and prolapse of pelvic organs; retail store services featuring user-specific medical devices for inter-vaginal use in administering pharmaceutical agents, namely, hormones, spermicides, proteins, and regenerative medicines; providing a website featuring consumer product information about medical devices for preventing urinary incontinence and prolapse of pelvic organs; providing a website featuring consumer product information about gynecological medical instruments for examining and measuring a women's reproductive organs; providing on-line consumer product information about medical devices for preventing urinary incontinence and prolapse of pelvic organs; providing on-line consumer product information about gynecological medical instruments for examining and measuring a women's reproductive organsACTIVE—
042Providing on-line non-downloadable software for monitoring implanted medical devices, including implanted medical prostheses, for preventing female stress urinary incontinence, urinary incontinence and prolapse of pelvic organsACTIVE—
044Leasing and rental of user-specific medical devices for preventing female stress urinary incontinence, urinary incontinence and prolapse of pelvic organs; leasing and rental of user- specific medical devices for treating and diagnosing urinary incontinence and prolapse of pelvic organs; leasing and rental of user-specific medical devices, namely, pessaries for managing symptoms of female stress urinary incontinence, urinary incontinence and prolapse of pelvic organs; leasing and rental of user-specific medical devices for inter-vaginal use in administering pharmaceutical agents, namely, hormones, spermicides, proteins, and regenerative medicines; providing a website featuring medical information about medical devices for preventing urinary incontinence and prolapse of pelvic organs; providing a website featuring medical information about gynecological medical instruments for examining and measuring a women's reproductive organs; providing on-line medical information about medical devices for preventing urinary incontinence and prolapse of pelvic organs; providing on-line medical information about gynecological medical instruments for examining and measuring a women's reproductive organsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 28, 2026RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Apr 30, 2026GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Apr 30, 2026GNSLLETTER OF SUSPENSION E-MAILED—
Apr 30, 2026CNSLSUSPENSION LETTER WRITTEN—
Apr 20, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 20, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 20, 2026ALIEASSIGNED TO LIE—
Apr 15, 2026ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Jan 16, 2026GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Jan 16, 2026GNSIINQUIRY TO SUSPENSION E-MAILED—
Jan 16, 2026CNSISUSPENSION INQUIRY WRITTEN—
Nov 18, 2025RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
May 17, 2025GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
May 17, 2025GNSLLETTER OF SUSPENSION E-MAILED—
May 17, 2025CNSLSUSPENSION LETTER WRITTEN—
May 14, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 14, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 14, 2025ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
May 13, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 13, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 13, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 13, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 13, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Feb 14, 2025GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Feb 14, 2025GNSIINQUIRY TO SUSPENSION E-MAILED—
Feb 14, 2025CNSISUSPENSION INQUIRY WRITTEN—
Feb 10, 2025RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Jul 22, 2024GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jul 22, 2024GNSLLETTER OF SUSPENSION E-MAILED—
Jul 22, 2024CNSLSUSPENSION LETTER WRITTEN—
May 31, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 31, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 31, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 1, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 1, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 1, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 28, 2024DOCKASSIGNED TO EXAMINER—
Jul 12, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 12, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance